A Common Polymorphism Renders the Luteinizing Hormone Receptor Protein More Active by Improving Signal Peptide Function and Predicts Adverse Outcome in Breast Cancer Patients-Reference-Cited by-同舟云学术

A Common Polymorphism Renders the Luteinizing Hormone Receptor Protein More Active by Improving Signal Peptide Function and Predicts Adverse Outcome in Breast Cancer Patients

Published:2006-04 Issue:4 Volume:91 Page:1470-1476
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:The Journal of Clinical Endocrinology & Metabolism

Author:

Piersma Djura,Berns Els M. J. J.,Verhoef-Post Miriam,Uitterlinden Andre G.,Braakman Ineke,Pols Huibert A. P.,Themmen Axel P. N.

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Restoring function to inactivating G protein‐coupled receptor variants in the hypothalamic–pituitary–gonadal axis¹;Journal of Neuroendocrinology;2024-06-09

2. Mitochondrial Dynamics as Potential Modulators of Hormonal Therapy Effectiveness in Males;Biology;2023-04-03

3. Effect Modification of LHCGR Gene Variant (rs2293275) on Clinico-Biochemical Profile, and Levels of Luteinizing Hormone in Polycystic Ovary Syndrome Patients;Biochemical Genetics;2023-01-12

4. Effect modification of luteinizing hormone chorionic gonadotropin hormone receptor gene variant (rs2293275) on clinical and biochemical profile, and levels of luteinizing hormone in polycystic ovary syndrome patients;2022-09-01

5. Genetic polymorphisms of reproductive hormones and their receptors in assisted reproduction technology for patients with polycystic ovary syndrome;Drug Metabolism and Personalized Therapy;2021-12-01